dc.contributor.author | Negredo, Anabel | |
dc.contributor.author | Sánchez-Ledesma, María | |
dc.contributor.author | Llorente, Francisco | |
dc.contributor.author | Perez-Olmeda, Mayte | |
dc.contributor.author | Belhassen-García, Moncef | |
dc.contributor.author | González-Calle, David | |
dc.contributor.author | Sanchez-Seco, Paz | |
dc.contributor.author | Jiménez-Clavero, Miguel Ángel | |
dc.date.accessioned | 2021-12-13T11:45:15Z | |
dc.date.available | 2021-12-13T11:45:15Z | |
dc.date.issued | 2021-06 | |
dc.identifier.citation | Emerg Infect Dis. 2021; 27(6): 1754-1756 | es_ES |
dc.identifier.issn | 1080-6040 | es_ES |
dc.identifier.uri | http://hdl.handle.net/20.500.12105/13487 | |
dc.description.abstract | Before this report, 7 autochthonous human cases of Crimean-Congo hemorrhagic fever had been reported in Spain, all occurring since 2016. We describe the retrospective identification of an eighth case dating back to 2013. This study highlights that the earliest cases of an emerging disease are often difficult to recognize. | es_ES |
dc.description.sponsorship | This study has been supported in part from ISCIII, Project RD16CIII/0003/0003, “Red de Enfermedades Tropicales,” Subprogram RETICS Plan Estatal de I+D+I 2013-2016, and cofunded by FEDER “Una manera de hacer Europa.” | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Centers for Disease Control and Prevention | es_ES |
dc.relation.isversionof | Publisher's version | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.subject | CCHF | es_ES |
dc.subject | CCHFV | es_ES |
dc.subject | Crimean-Congo hemorrhagic fever virus | es_ES |
dc.subject | Spain | es_ES |
dc.subject | Antibodies | es_ES |
dc.subject | Emerging communicable diseases | es_ES |
dc.subject | Parasites | es_ES |
dc.subject | Ticks | es_ES |
dc.subject | Vector-borne infections | es_ES |
dc.title | Retrospective Identification of Early Autochthonous Case of Crimean-Congo Hemorrhagic Fever, Spain, 2013 | es_ES |
dc.type | Artículo | es_ES |
dc.rights.license | Atribución 4.0 Internacional | * |
dc.identifier.pubmedID | 34013861 | es_ES |
dc.format.volume | 27 | es_ES |
dc.format.number | 6 | es_ES |
dc.format.page | 1754-1756 | es_ES |
dc.identifier.doi | 10.3201/eid2706.204643 | es_ES |
dc.contributor.funder | Instituto de Salud Carlos III | es_ES |
dc.contributor.funder | European Regional Development Fund (ERDF/FEDER) | es_ES |
dc.description.peerreviewed | Sí | es_ES |
dc.identifier.e-issn | 1080-6059 | es_ES |
dc.relation.publisherversion | DOI: https://doi.org/10.3201/eid2706.204643 | es_ES |
dc.identifier.journal | Emerging Infectious Diseases | es_ES |
dc.repisalud.centro | ISCIII::Centro Nacional de Microbiología | es_ES |
dc.repisalud.institucion | ISCIII | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/ES/RD16CIII/0003/0003 | es_ES |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | es_ES |